Product Information

ZOVIA 1-35 TABLET is a generic product labeled by Mayne Pharma, priced at $0.3449 per EA under NDC 51862089401. Its NADAC has been published 207 times since Oct 20, 2021.

FDA first approved this application on Feb 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

Manufacturer

Mayne Pharma

NDC

51862089401

Classification

Generic

Dosage Form

KIT

Effective Date

9/17/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA209548

FDA Approved

2/11/2019

TE Code

AB

On Market Since

10/16/2020

Price Statistics

The NADAC for ZOVIA 1-35 TABLET has been published 207 times since Oct 20, 2021, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3449 per EA
All-time high$0.5719 (Dec 15, 2021)
All-time low$0.2253 (Nov 20, 2024)
52-week high$0.3683
52-week low$0.3449
Median price$0.3724
Average price$0.3758
Largest weekly change+53.0% (Jun 19, 2024)
Weeks tracked207
Tracking sinceOct 20, 2021

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

-6.4%

3Y

-21.4%

5Y

N/A

All

-13.3%

Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of ZOVIA 1-35 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZOVIA 1-35 TABLET, manufactured by Mayne Pharma, is $0.3449 per EA (NDC 51862089401), effective Oct 1, 2025.

How has the price of ZOVIA 1-35 TABLET changed over time?

Over the history we have for it, the NADAC for ZOVIA 1-35 TABLET has declined 13.3%. It has been tracked across 207 weekly CMS publications since Oct 20, 2021.

What are the highest and lowest recorded NADAC prices for ZOVIA 1-35 TABLET?

Since Oct 20, 2021, the NADAC for ZOVIA 1-35 TABLET has ranged from a low of $0.2253 (Nov 20, 2024) to a high of $0.5719 (Dec 15, 2021), with a median of $0.3724 per EA.

Are there cheaper alternatives to ZOVIA 1-35 TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZOVIA 1-35 TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZOVIA 1-35 TABLET?

ZOVIA 1-35 TABLET (NDC 51862089401) is labeled by Mayne Pharma, and CMS classifies it as a generic product.